An open-label randomised observer-blind study to evaluate 24-hour intragastric pH profile at day 1 and day 14 during treatment with a fixed combination of a histamine type 2 receptor antagonist and a proton pump inhibitor.
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2011
At a glance
- Drugs Famotidine/omeprazole (Primary) ; Famotidine; Omeprazole
- Indications Heartburn
- Focus Therapeutic Use
- 26 Jul 2011 New trial record